NYSE:TEVA

Teva Pharmaceutical Industries SEC Filings & 10K Form

$8.94
+0.13 (+1.48 %)
(As of 07/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.79
$8.99
50-Day Range
$8.38
$11.53
52-Week Range
$8.24
$13.30
Volume7.77 million shs
Average Volume9.07 million shs
Market Capitalization$9.76 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.46

Teva Pharmaceutical Industries (NYSE:TEVA) SEC Filings

DateFilerForm TypeView
07/21/2021
7:00 AM
Teva Pharmaceutical Industries (Filer)
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2021
7:23 AM
Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
7:22 AM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
7:21 AM
Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
7:20 AM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
7:20 AM
MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
7:19 AM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
7:18 AM
Hussain Abbas (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
7:15 AM
Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
7:13 AM
Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
7:12 AM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
7:10 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
7:12 AM
Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
6:47 AM
Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
6:46 AM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
6:45 AM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
6:43 AM
MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
6:42 AM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
6:41 AM
Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
6:40 AM
Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
6:39 AM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
6:39 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
7:19 AM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
6:32 AM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
6:30 AM
Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
6:30 AM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
6:29 AM
MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
6:27 AM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
6:26 AM
Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
6:25 AM
Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
6:23 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
7:41 AM
Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
6:48 AM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
6:46 AM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
6:45 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
6:44 AM
Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2021
3:13 PM
Teva Pharmaceutical Industries (Filer)
Form DEFA14A
04/21/2021
3:11 PM
Teva Pharmaceutical Industries (Filer)
Form DEF 14A
02/17/2021
3:11 PM
Teva Pharmaceutical Industries (Issuer)
Weil Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/17/2021
3:09 PM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:08 PM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:07 PM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
2:58 PM
Capital Research Global Investors (Filed by)
Teva Pharmaceutical Industries (Subject)
Form SC 13G/A
02/11/2021
3:12 PM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2021
12:13 PM
Teva Pharmaceutical Industries (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/25/2021
3:02 PM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
3:09 PM
Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2020
6:42 AM
Schultz Kare (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
8:04 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:11 PM
Hussain Abbas (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:09 PM
Hussain Abbas (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/17/2020
11:15 PM
Teva Pharmaceutical Finance Netherlands II B.V. (Filer)
Teva Pharmaceutical Finance Netherlands III B.V. (Filer)
Teva Pharmaceutical Industries (Filer)
Form EFFECT
08/17/2020
8:12 AM
Teva Pharmaceutical Finance Netherlands II B.V. (Filer)
Teva Pharmaceutical Finance Netherlands III B.V. (Filer)
Teva Pharmaceutical Industries (Filer)
Form 424B3
08/14/2020
10:17 AM
Teva Pharmaceutical Industries (Filer)
Form SD
Specialized Disclosure Report  
08/13/2020
3:15 PM
Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
3:14 PM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
3:13 PM
MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
3:12 PM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
3:09 PM
Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
3:07 PM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
3:06 PM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
3:16 PM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2020
3:47 PM
Teva Pharmaceutical Finance Netherlands II B.V. (Filer)
Teva Pharmaceutical Finance Netherlands III B.V. (Filer)
Teva Pharmaceutical Industries (Filer)
Form S-4
Registration statement under Securities Act of 1933  
08/05/2020
3:43 PM
Teva Pharmaceutical Industries (Filer)
Form S-8 POS
08/05/2020
3:42 PM
Teva Pharmaceutical Industries (Filer)
Form S-8 POS
08/05/2020
3:42 PM
Teva Pharmaceutical Industries (Filer)
Form S-8 POS
08/05/2020
6:01 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
6:37 AM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:36 AM
Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:35 AM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:35 AM
MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:34 AM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:33 AM
Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:32 AM
Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:31 AM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:31 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:18 AM
Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:17 AM
Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2020
6:16 AM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:15 AM
Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:14 AM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:13 AM
MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:13 AM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:12 AM
Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:11 AM
Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:10 AM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:09 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:28 AM
Teva Pharmaceutical Industries (Filer)
Form DEFA14A
05/07/2020
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2020
6:57 AM
Teva Pharmaceutical Industries (Filer)
Form DEFA14A
04/22/2020
6:54 AM
Teva Pharmaceutical Industries (Filer)
Form DEF 14A
03/19/2020
3:19 PM
Teva Pharmaceutical Industries (Filer)
Form PRE 14A
03/19/2020
7:09 AM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
6:38 AM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
6:37 AM
O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
6:36 AM
Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
6:33 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.